Primary hyperoxaluria: The Baragwanath experience
Article Sidebar
Main Article Content
Abstract
Background. Primary hyperoxaluria (PH) is a rare autosomal recessive condition characterised by defects in the metabolism of glyoxylate which leads to excess oxalate production. It is an important disease to diagnose as it can progress to kidney failure (KF).
Objective. To describe the characteristics, diagnosis and management of PH in South Africa and to identify any determinants of KF and death.
Method. A retrospective study of all children younger than 16 years of age, diagnosed with PH at the Paediatric Renal Unit, Chris Hani Baragwanath Academic Hospital, from 1984 - 2017.
Results. A total of 24 patients were identified, of which 20 records were available for complete analysis. The median age of presentation was 6.0 years. The common clinical presentations were urolithiasis (90%), KF (85%), nephrocalcinosis (75%), urinary tract infections (55%) and haematuria (30%). Nephrocalcinosis was better detected on abdominal radiograph compared with ultrasonography. Both nephrocalcinosis (p=0.009) and haematuria (p=0.018) were significantly associated with KF. Five patients had A112D genetic mutation in the AGXT. Fourteen received dialysis and four were transplanted. The mortality rate in this study was 58.3%.
Conclusion. Clinicians should have a high index of suspicion for PH in patients presenting with haematuria, urolithiasis and KF. This study supports the measurement of urine oxalate levels and abdominal radiographs in screening for PH in children presenting in KF.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med 2013;369(7):649-658. https://doi.org/10.1056%2Fnejmra1301564
Cochat P, Liutkus A, Fargue S, Basmaison O, Ranchin B, Rolland MO. Primary hyperoxaluria type 1: Still challenging! Pediat Nephrol 2006;21(8):1075-1081. https://doi.org/10.1007%2Fs00467-006-0124-4
Hoppe B, Latta K, von Schnakenburg C, Kemper MJ. Primary hyperoxaluriathe German experience. Am J Nephrol 2005;25(3):276-281. https://doi.org/10.1159%2F000086358
Almardini RI, Alfarah MG, Salaita GM. The clinical pattern of primary hyperoxaluria in pediatric patient at Queen Rania Abdulla Children Hospital. Arab J Nephrol Transplant 2014;7(2):119-123.
Gargah T, Khelil N, Youssef G, Karoui W, Lakhoua MR, Abdelmoula J. Primary hyperoxaluria type 1 in Tunisian children. Saudi J Kidney Dis Transpl 2012;23(2):385-390. https://pubmed.ncbi.nlm.nih.gov/22382246/
Soliman NA, Nabhan MM, Abdelrahman SM, et al. Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center. Nephrol Ther 2017;13(3):176-182. https://doi.org/10.1016%2Fj.nephro.2016.08.002
Hoppe B, Beck BB, Milliner DS. The primary hyperoxalurias. Kidney Int 2009;(75): 1264-1271. https://doi.org/10.1038%2Fki.2009.32
Takayama T, Nagata M, Ichiyama A, Ozono S. Primary hyperoxaluria type 1 in Japan. Am J Nephrol 2005;25(3):297-302. https://doi.org/10.1159%2F000086361
van Woerden CS, Groothoff JW, Wanders RJ, Davin JC, Wijburg FA. Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 2003;18(2):273-279. https://doi.org/10.1093%2Fndt%2F18.2.273
Al Riyami MS, Al Ghaithi B, Al Hashmi N, Al Kalbani N. Primary hyperoxaluria type 1 in 18 children: genotyping and outcome. Int J Nephrol. 2015:1-6. https://doi.org/10.1155%2F2015%2F634175
Singh DR, Sagade SN, Kamat MH, Deshpande RB, Shah BV. Oxalosis with nephrocalcinosis. Nephrol Dial Transplant 2000;15(1):124-125. https://doi.org/10.1093%2Fndt%2F15.1.124
Orazi C, Picca S, Schingo PMS, Fassari FM, Canepa G. Oxalosis in primary hyperoxaluria in infancy: Report of a case in a 3-month-old baby. Follow-up for 3 years and review of literature. Skeletal Radiol 2009;38(4):387-391. https://doi.org/10.1007%2Fs00256-008-0625-2
Tang XJ, Bergstralh EJ, Mehta RA, Vrtiska TJ, Milliner DS, Lieske JC. Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria.
Kidney Int 2015;87(3):623-631. https://doi.org/10.1038%2Fki.2014.298
Cheidde L, Ajzen SA, Langen CHT, Christophalo D, Heilberg IP. A critical appraisal of the radiological evaluation of nephrocalcinosis. Nephron Clin Pract 2007;106(3):119-124. https://doi.org/10.1159%2F000102999
Hashmi SB, Jafri L, Majid H, Talati J, Aziz W, Khan AH. Relationship of spot urine oxalate to creatinine ratio and 24 hours urinary oxalate excretion in patients with urolithiasis. Ann Med Surg (Lond) 2020;60:330-333. https://doi.org/10.1016/j.amsu.2020.11.002
Clifford-Mobley O, Tims C, Rumsby G. The comparability of oxalate excretion and oxalate: creatinine ratio in the investigation of primary hyperoxaluria: review of data from a referral centre. Ann Clin Biochem 2015;52(1):113-121. https://doi.org/10.1177%2F0004563214529937
Coulter-Mackie MB, Tung A, Henderson HE, Toone JR, Applegarth DA. The AGT gene in Africa: a distinctive minor allele haplotype, a polymorphism (V326I), and a novel PH1 mutation (A112D) in Black Africans. Mol Genet Metab. 2003;78(1):44-50. https://doi.org/10.1016%2Fs1096-7192%2802%2900204-4
Mookadam F, Smith T, Jiamsripong P, et al. Cardiac Abnormalities in Primary Hyperoxaluria. Circ J 2010;74(11):2403-2409. https://doi.org/10.1253%2Fcircj.cj-10-0107
Yoshioka J, Park YD, Tanaka Y, et al. Echocardiographic Features in a Patient with Primary Oxalosis. Echocardiography 2001;18(7):599-602. https://doi.org/10.1046%2Fj.1540-8175.2001.00599.x
Bello A, Sangweni B, Mudi A, Khumalo T, Moonsamy G, Levy C. The financial cost incurred by families of children on long-term dialysis. Perit Dial Int 2018;38(1):14-17. https://doi.org/10.3747%2Fpdi.2017.00092